Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer

被引:3
|
作者
Dumont, E. [1 ]
Dartigues, P. [2 ]
Delga, B. [1 ]
Thibaudeau, E. [1 ]
Benhaim, L. [3 ]
Campion, L. [4 ]
Mosnier, J. F. [5 ]
Raimbourg, J. [6 ]
Kerdraon, O. [7 ]
Goere, D. [3 ]
机构
[1] West Oncol Inst, Dept Digest Oncol Surg, St Herblain, France
[2] Gustave Roussy Canc Campus, Dept Pathol, Villejuif, France
[3] Gustave Roussy Canc Campus, Dept Digest Oncol Surg, Villejuif, France
[4] West Oncol Inst, Dept Stat, St Herblain, France
[5] Univ Hosp, Dept Pathol, Nantes, France
[6] West Oncol Inst, Dept Oncol, St Herblain, France
[7] West Oncol Inst, Dept Pathol, St Herblain, France
来源
AMERICAN JOURNAL OF SURGERY | 2018年 / 216卷 / 03期
关键词
Rectal cancer; Chemoradiotherapy; Nodal staging; Lymph node; Chemoradiotherapy T status; Good response; PATHOLOGICAL COMPLETE RESPONSE; LYMPH-NODE METASTASES; PREOPERATIVE CHEMORADIATION; NEOADJUVANT CHEMORADIOTHERAPY; RANDOMIZED-TRIAL; LOCAL EXCISION; METAANALYSIS; CARCINOMA; THERAPY; OXALIPLATIN;
D O I
10.1016/j.amjsurg.2018.03.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The purpose of this study was to identify the predictive factors for ypN0 status in tumors with good pathologic response to chemoradiotherapy (CRT). Methods: A retrospective chart review was conducted on patients at two tertiary cancer center who underwent rectal resection after good response to CRT between 2000 and 2013. Results: No preoperative treatment (oxaliplatin use, radiotherapy boost of 5,4 Gy, delay CRT-surgery) impacted on the ypN status. In the multivariate analysis, only a ypT<3 (HR 7.5 [2,9-19.5]) was significant and no lymphovascular invasion (HR 8,9 [1.6-49.8]) was limited to significance.The best model predicting the ypN0 status used only the ypT status<3. The major part (92.2%) of patients with ypT0-2 tumors had no LN invasion. Conclusion: The risk of lymph node involvement metastases was only 7.8% for the patients with an ypT0-2 status. A fullthickness transanal resection coud be the futur treatment of these patients. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 50 条
  • [11] Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
    Kai-yun You
    Rong Huang
    Pei-rong Ding
    Bo Qiu
    Guan-qun Zhou
    Hui Chang
    Wei-wei Xiao
    Zhi-fan Zeng
    Zhi-zhong Pan
    Yuan-hong Gao
    International Journal of Colorectal Disease, 2014, 29 : 529 - 538
  • [12] Prognostic Value of Mesorectal Lymph Node Micrometastases in ypN0 Rectal Cancer After Chemoradiation
    Kang, Byung Mo
    Park, Jun-Seok
    Kim, Hye Jin
    Park, Soo Yeon
    Yoon, Ghilsuk
    Choi, Gyu-Seog
    JOURNAL OF SURGICAL RESEARCH, 2022, 276 : 314 - 322
  • [13] Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy
    Kyung-Ha Lee
    Jae-Chan Kim
    Ji-Yeon Kim
    Jin-Su Kim
    International Journal of Colorectal Disease, 2015, 30 : 1041 - 1050
  • [14] Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy
    Lee, Kyung-Ha
    Kim, Jae-Chan
    Kim, Ji-Yeon
    Kim, Jin-Su
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (08) : 1041 - 1050
  • [15] Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision
    Govindarajan, Anand
    Reidy, Diane
    Weiser, Martin R.
    Paty, Philip B.
    Temple, Larissa K.
    Guillem, Jose G.
    Saltz, Leonard B.
    Wong, W. Douglas
    Nash, Garrett M.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (13) : 3666 - 3672
  • [16] Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision
    Anand Govindarajan
    Diane Reidy
    Martin R. Weiser
    Philip B. Paty
    Larissa K. Temple
    Jose G. Guillem
    Leonard B. Saltz
    W. Douglas Wong
    Garrett M. Nash
    Annals of Surgical Oncology, 2011, 18 : 3666 - 3672
  • [17] Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
    Trotsyuk, Iryna
    Sparschuh, Halina
    Mueller, Alice Josephine
    Neumann, Konrad
    Kruschewski, Martin
    Horst, David
    Elezkurtaj, Sefer
    BMC CANCER, 2019, 19 (01)
  • [18] Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved
    Han Tang
    Lijie Tan
    Hao Wang
    Yaxing Shen
    Jun Yin
    Journal of Gastrointestinal Surgery, 2020, 24 : 1469 - 1476
  • [19] Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
    Iryna Trotsyuk
    Halina Sparschuh
    Alice Josephine Müller
    Konrad Neumann
    Martin Kruschewski
    David Horst
    Sefer Elezkurtaj
    BMC Cancer, 19
  • [20] Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved
    Tang, Han
    Tan, Lijie
    Wang, Hao
    Shen, Yaxing
    Yin, Jun
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (07) : 1469 - 1476